Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma.
Future Oncology.
2020,
17(3),
241-254,
ISSN: 1479-6694,
PMID: 33016119,